Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 797

Chimote G, Banerjee R (2009) Evaluation of antitubercular drug-loaded surfactants as inhalable
drug-delivery systems for pulmonary tuberculosis. J Biomed Mater Res A 89: 281-292
Chimote G, Banerjee R (2010) In vitro evaluation of inhalable isoniazid-loaded surfactant lipo-
somes as an adjunct therapy in pulmonary tuberculosis. JBiomed Mater Res B Appl Biomater
94(1): 1-10
Chono S, Tanino T, Seki T, Morimoto K (2007) Uptake characteristics of liposomes by rat alveolar
macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol
59: 75-80
Chono S, Tanino T, Seki T, Morimoto K (2008) Efficient drug targeting to rat alveolar mac-
rophages by pulmonary administration of ciprofloxacin incorporated into mannosylated
liposomes for treatment of respiratory intracellular parasitic infections. J Control Release 127:
50-58
Clark A, Reed KA, Lodge J, Stephen J, Hirst BH, Jepson MA (1996) Invasion of murine intestinal
M cells by Salmonella typhimurium inv mutants severely deficient for invasion of cultured
cells. Infect Immun 64: 4363-4368
Clayton J (2010) Chagas disease. Nature 465: S4-S5
Clemens DL, Lee BY, Horwitz MA (2004) Virulent and avirulent strains of Francisella tularensis
prevent acidification and maturation of their phagosomes and escape into the cytoplasm in
human macrophages. Infect Immun 72: 3204-3217
Coester CJ, Langer K, Van-Briesen H, Kreuter J (2000) Gelatin nanoparticles by two-step desol-
vation - a new preparation method, surface modifications and cell uptake. J Microencapsul 17:
187-193
Coltel N, Combes V, Hunt NH, Grau GE (2004) Cerebral malaria - a neurovascular pathology
with many riddles still to be solved. Curr Neurovasc Res 1: 91-110
Cometta A, Glauser MP (1996) The use of aminoglycosides in neutropenic patients. SCh Med
Wochensch S, 76: 21 S-7 S
Conley J, Yang H, Wilson T, Blasetti K, Di Ninno V, Schnell G, Wong JP (1997) Aerosol delivery
of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against
Francsella tularensis infection in mice. Antimicrob Agents Chemother 41: 1288-1292
Cook PJ, Davies P, Tunnicliffe W, Ayeres JG, Honeybourne D, Wise R (1998) Chlamydia pneu-
moniae and asthma. Thorax 53: 254-259
Cordeiro C, Wiseman DJ, Lutwyche P, Uh M, Evans JC, Finlay BB, Webb MS (2000) Antibacterial
efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella
enterica serovar typhimurium intracellular infection model. Antimicrob Agents Chemother 44
(3): 533-539
Cosma CL, Sherman DR, Ramakrishnan L (2003) The secret lives of pathogenic mycobacteria.
Annu Rev Microbiol 57: 641-676
Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesquière A, Desmonts G (1991) Fetal
toxoplasmosis. In utero treatment with pyrimethamine sulfamides . Arch Fr Pediatr 48(6):
397-403
Croft SL, Coombs GH (2003) Leishmaniasis-current chemotherapy and recent advances in the
search for novel drugs. Trends Parasitol 19: 502-507
Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50:
241-246
Cryan S-A, Sivadas N, Garcia-Contreras L (2007) In vivo animal models for drug delivery across
the lung mucosal barrier. Adv Drug Del Rev 59: 1133-1151
Csaba N, Garcia-Fuentes M, Alonso MJ (2009) Nanoparticles for nasal vaccination. Adv Drug
Del Rev 61: 140-157
Cullis PR, Hope MJ, Bally MB, Madden TD, Mayer LD, Fenske DB (1997) Influence of pH
gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unila-
mellar vesicles. Biochim Biophys Acta 1331: 187-211
Cunningham AC (2002) Parasitic adaptive mechanisms in infection by Leishmania . Exp Mol
Pathol 72: 132-141